Madrigal Pharmaceuticals, Inc. (MDGL) Revenue History
Madrigal Pharmaceuticals, Inc. (MDGL) annual and quarterly revenue history with charts. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | N/A |
| 2024-12-31 | $180.13M |
| 2025-12-31 | $958.40M |
How MDGL compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| IONS | Ionis Pharmaceuticals Inc. | $943.71M |
| BCRX | BioCryst Pharmaceuticals Inc. | $874.84M |
| NEOG | Neogen Corporation | $870.40M |
| INNV | InnovAge Holding Corp. | $853.70M |
| VREX | Varex Imaging Corporation | $844.60M |
These are five companies in the same sector as MDGL with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Madrigal Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("MDGL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | MDGL | $536.20 | +0.17% | 0.29M |
| 3 | ||||
| 4 | ||||
| 5 |